The economic burden and quality of life of patients with psoriasis treated with biologics in China
Background Although biologics improve the quality of life of psoriasis patients, they also impose a substantial economic burden. There is a lack of research addressing the economic and humanistic impact of biologics in China. Objective This cross-sectional investigation aims to assess the economic c...
Saved in:
Main Authors: | Shuhui Min (Author), Danfeng Wang (Author), Jiali Xia (Author), Xiao Lin (Author), Guan Jiang (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2023-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Economic Burden and Quality of Life of Hepatocellular Carcinoma in Greater China: A Systematic Review
by: Huimin Zou, et al.
Published: (2022) -
Economic burden of psoriasis in Southern Iran in 2022
by: Ramin Ravangard, et al.
Published: (2024) -
Health-related quality of life and economic burden of childhood pneumonia in China: a multiregion study
by: Mark Jit, et al.
Published: (2023) -
Dermatology Life Quality Index in Patients with Psoriasis Treated with Biologic Versus Non-biologic Treatment in Malaysia: A Retrospective Cross-Sectional Study
by: Suganthy Robinson, et al.
Published: (2023) -
Psoriasis in areas difficult to treat and biological therapy
by: Anna Lis-Święty, et al.
Published: (2021)